Institute of Pathology

Long-term endothelial dysfunction in irradiated vessels: an immunohistochemical analysis (2019) Preidl R, Möbius P, Weber M, Amann KU, Neukam FW, Kesting MR, Geppert CI, Wehrhan F Journal article Quantitative assessment of microperfusion by indocyanine green angiography in kidney transplantation resembles chronic morphological changes in kidney specimens (2019) Rother U, Amann KU, Adler W, Nawroth N, Karampinis I, Keese M, Manap S, et al. Journal article Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands (2019) Haller F, Bieg M, Will R, Koerner C, Weichenhan D, Bott A, Ishaque N, et al. Journal article ESC Working Group on Cellular Biology of the Heart: Tissue Engineering and Cell-Based Therapies for Cardiac Repair in Ischemic Heart Disease and Heart Failure (2019) Madonna R, Van Laake LW, Botker HE, Davidson SM, De Caterina R, Engel F, Eschenhagen T, et al. Journal article MSI status plus immunoscore to select metastatic colorectal cancer patients for immunotherapies (2018) Galon J, Mlecnik B, Hermitte F, Marliot F, Bifulco C, Lugli A, Nagtegaal ID, et al. Conference contribution Successful Long-term Treatment of Diversion Colitis with Topical Coconut Oil Application (2018) Zundler S, Dietz L, Matzel KE, Geppert CI, Becker E, Rath T, Neurath M, Atreya R Journal article, Letter Nephron-specific knockout of TMEM16A leads to reduced number of glomeruli and albuminuria (2018) Schenk LK, Buchholz B, Henke SF, Michgehl U, Daniel C, Amann KU, Kunzelmann K, Pavenstaedt H Journal article GRADING CONSIDERATIONS FOR MENINGEAL SOLITARY FIBROUS TUMOR/HEMANGIOPERICYTOMA (2018) Fritchie K, Jensch K, Jenkins S, Link M, Brown PD, Rodriguez F, Guajardo A, et al. Conference contribution Immunoscore feasibility study in routine postsurgical pathologic review for early-stage colon cancer (CC) cases risk-assessment (2018) Belaloui K, Malifarge E, Bohm J, Bossard C, Dienstmann R, Garcia S, Geppert CI, et al. Conference contribution A prediction model for pathological complete response after neoadjuvant chemotherapy of HER2-negative breast cancer patients (2018) Häberle L, Erber R, Gaß P, Hein A, Jud S, Langemann H, Rauh C, et al. Conference contribution